Imaging malignant melanoma with F-18-5-FPN

Purpose Radiolabelled benzamides are attractive candidates for targeting melanoma because they bind to melanin and exhibit high tumour uptake and retention. F-18-5-Fluoro-N--(2-[diethylamino]ethyl)picolinamide (F-18-5-FPN), a benzamide analogue, was prepared and its pharmacokinetics and binding affinity evaluated both in vitro and in vivo to assess its clinical potential in the diagnosis and staging of melanoma. Methods F-18-5-FPN was prepared and purified. Its binding specificity was measured in vitro in two different melanoma cell lines, one pigmented (B16F10 cells) and one nonpigmented (A375m cells), and in vivo in mice xenografted with the same cell lines. Dynamic and static PET images using F-18-5-FPN were obtained in the tumour-bearing mice, and the static images were also compared with those acquired with F-18-FDG. PET imaging with F-18-5-FPN was also performed in B16F10 tumour-bearing mice with lung metastases. Results F-18-5-FPN was successfully prepared with radiochemical yields of 5 - 10 %. Binding of F-18-5-FPN to B16F10 cells was much higher than to A375m cells. On dynamic PET imaging B16F10 tumours were visible about 1 min after injection of the tracer, and the uptake gradually increased over time. F-18-5-FPN was rapidly excreted via the kidneys. B16F10 tumours were clearly visible on static images acquired 1 and 2 h after injection, with high uptake values of 24.34 +/- 6.32 %ID/g and 16.63 +/- 5.41 %ID/g, respectively, in the biodistribution study (five mice). However, there was no visible uptake by A375m tumours. F-18-5-FPN and F-18-FDG PET imaging were compared in B16F10 tumour xenografts, and the tumour-to-background ratio of F-18-5-FPN was ten times higher than that of F-18-FDG (35.22 +/- 7.02 vs. 3.29 +/- 0.53, five mice). F-18-5-FPN PET imaging also detected simulated lung metastases measuring 1 - 2 mm. Conclusion F-18-5-FPN specifically targeted melanin in vitro and in vivo with high retention and affinity and favourable pharmacokinetics. F-18-5-FPN may be an ideal molecular probe for melanoma diagnosis and staging.